Search

Your search keyword '"van der Bij, Wim"' showing total 9 results
Start Over Author "van der Bij, Wim" Publisher american thoracic society
9 results on '"van der Bij, Wim"'

4. Sputum Induction in Research

Author

van den Berg, Jan Willem, primary, Kerstjens, Huib, additional, Postma, Dirkje, additional, van der Bij, Wim, additional, and Koëter, Gerard, additional

Published
2003
Full Text
View/download PDF

6. Eosinophilic Granulocytes and Interleukin-6 Level in Bronchoalveolar Lavage Fluid Are Associated with the Development of Obliterative Bronchiolitis after Lung Transplantation

Author

SCHOLMA, JANNY, primary, SLEBOS, DIRK-JAN, additional, MARIKE BOEZEN, H., additional, van den BERG, JAN W. K., additional, van der BIJ, WIM, additional, de BOER, WIM J., additional, KOËTER, GERARD H., additional, TIMENS, WIM, additional, KAUFFMAN, HENK F., additional, and POSTMA, DIRKJE S., additional

Published
2000
Full Text
View/download PDF

9. Lung transplantation for cystic fibrosis.

Author

Adler FR, Aurora P, Barker DH, Barr ML, Blackwell LS, Bosma OH, Brown S, Cox DR, Jensen JL, Kurland G, Nossent GD, Quittner AL, Robinson WM, Romero SL, Spencer H, Sweet SC, van der Bij W, Vermeulen J, Verschuuren EA, Vrijlandt EJ, Walsh W, Woo MS, and Liou TG

Subjects
Child, Humans, Cystic Fibrosis surgery, Lung Transplantation
Abstract

Lung transplantation is a complex, high-risk, potentially life-saving therapy for the end-stage lung disease of cystic fibrosis (CF). The decision to pursue transplantation involves comparing the likelihood of survival with and without transplantation as well as assessing the effect of wait-listing and transplantation on the patient's quality of life. Although recent population-based analyses of the US lung allocation system for the CF population have raised controversies about the survival benefits of transplantation, studies from the United Kingdom and Canada have suggested a definite survival advantage for those receiving transplants. In response to these and other controversies, leaders in transplantation and CF met together in Lansdowne, Virginia, to consider the state of the art in lung transplantation for CF in an international context, focusing on advances in surgical technique, measurement of outcomes, use of prognostic criteria, variations in local control over listing, and prioritization among the United States, Canada, the United Kingdom, and The Netherlands, patient adherence before and after transplantation and other issues in the broader context of lung transplantation. Finally, the conference members carefully considered how efforts to improve outcomes for lung transplantation for CF lung disease might best be studied. This Roundtable seeks to communicate the substance of our discussions.

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results